Close
  • Home
  • Applications
      • Asset Management
      • Business Intelligence
      • CEM
      • Cognitive
      • Compliance
      • CRM
      • Data Center
      • E-Invoicing/E-Billing
      • Enterprise Communication
      • Enterprise Mobility
      • ERP
      • Facility Management
      • GDPR
      • Human Resource
      • Information Security
      • ITSM
      • Managed IT Services
      • MarTech
      • Payment and Card
      • Procurement
      • RegTech
      • Risk Management
      • RPA
      • Software Testing
      • Unified Communication
  • Verticals
      • Automotive
      • Casino Tech
      • Contact Center
      • Enterprise Startups
      • Field Service
      • FinTech
      • Healthcare
      • Legal Tech
      • PropTech
      • Telecom
      • Travel and Hospitality
  • Technologies
      • Agile
      • Artificial Intelligence
      • Augmented & Virtual Reality
      • Big Data
      • Blockchain
      • Cloud
      • Data Analytics
      • DevOps
      • Drone
      • HPC
      • IoT
      • Robotics
      • Smart City
      • Storage
  • Company Eco System
      • Adobe
      • Dassault Systemes
      • HPE
      • IBM
      • Microsoft
      • Oracle
      • Salesforce
      • SAP
  • News
  • conferences
  • Newsletter
  • Specials

  • Menu
      • Big Data
      • Blockchain
      • Casino Tech
      • CEM
      • Cloud
      • CRM
      • DevOps
      • Drone
      • Facility Management
      • GDPR
      • IoT
      • Legal Tech
      • Oracle
      • PropTech
      • RPA
  • Blockchain
  • Cloud
  • CRM
  • Drone
  • Facility Management
  • IoT
  • Oracle
Specials
  • Specials

  • Big Data
  • Blockchain
  • Casino Tech
  • CEM
  • Cloud
  • CRM
  • DevOps
  • Drone
  • Facility Management
  • GDPR
  • IoT
  • Legal Tech
  • Oracle
  • PropTech
  • RPA
×
#

CIO Applications Europe Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from CIO Applications Europe

Subscribe

loading
  • Home
  • Healthcare
Editor's Pick(1 - 4 of 8)
left
Seamlessly Operating Healthcare Institutes

Lisa Emery, CIO, West Hertfordshire Hospitals NHS Trust

Data Science Helps UCHealth Improve Infusion Center and Hospital Efficiency

Steve Hess, CIO, UCHealth

What is Serialisation in Pharma Industry?

Robert Jan van der Horst, CIO, DSM Sinochem Pharmaceuticals

Healthcare as it could be in 2030

Alan V. Abramson, Ph.D. SVP of Information Services & Technology & CIO, HealthPartners

Change Agents in a Digital Healthcare World: People, Culture and Strategy

Charles Koontz, President & CEO, GE Healthcare IT & Chief Digital Officer, GE Healthcare

Consumer APIs and the Impact On Healthcare Technology

Dr. David McCallie Jr., SVP, Medical Informatics at Cerner Corporation [NASDAQ:CERN]

Achieving Information Security in Healthcare

Dan Costantino, CISO, Penn Medicine

Implementation of HIT in Healthcare Practices

Susan DeVore, President and CEO, Premier

right

THANK YOU FOR SUBSCRIBING

Are Wearables and Sensors the Key to Disruptive Innovation in Clinical Trials-or Merely an Overhyped Distraction?

By Marie McCarthy, Director, Product Innovation, ICON plc

Tweet
content-image

Marie McCarthy, Director, Product Innovation, ICON plc

The existing clinical trial design is under increased scrutiny with lengthening trials, 9 out of 10 drug candidates failing and no new drugs available in some therapeutic areas such as Alzheimer’s disease in over 15 years. While there are a myriad of reasons, patient recruitment and retention are seen as key factors. Data from some trials suggest that over 85 percent of trials face delays and 30 percent never even get off the ground because of a lack of volunteers. In addition, there is concern that the outcome assessments currently in use may not be sufficiently sensitive to therapeutic response.

Making trials more accessible and attractive to patients; reducing the need to travel to the sites, and developing assessments with the potential to be more responsive to change is an industry obsession. Although activity trackers have been used by the research community since the 1970s, the launch of Bluetooth enabled fitness trackers and digital platforms in the early 2000s helped drive the digital revolution. These devices have caused considerable excitement in the industry and they are seen as having truly transformative potential. If one considers that a typical trial of 12-18 months has the potential to generate 9000 hours of data, but in a traditional trial only 50 hours of in-clinic assessments are captured. There are significant possibilities of identifying clinically responsive signals and unique biometric signatures in these real world continuous data streams generated by these devices.

But 10 years on what is the reality of the situation. The adoption of the accelerometer based fitness devices in drug development industry sponsored studies is still low with only 90 studies in Clinical Trials.gov detailing the use of these devices.
In the early adoption phase, the mHealth technology was almost a distraction, and was the focus of the study rather than the clinical value, or patients themselves. There was a view among some in the industry that one could purchase a number of smartwatches, hand them out to subjects, and generate data that could be used to support a clinical endpoint.

The use of wearables and sensors is moving towards patient-centric trials and the earlier availability of new therapies improving the lives of patients

Today the market has matured. There is a wide range of medical grade sensors and devices that can be used to capture a myriad of biometric data such as oximetry, heart rate, respiratory rate, and galvanic skin response. It is self-evident that a number of strategies need to be implemented in order to ensure the device selected is fit for purpose; has low patient burden, and generates the required clinical data. A number of industry led initiatives such as that led by ePRO Consortium, are striving to provide guidance around the evidence required to support the use of devices in a clinical trial. Other initiatives are ongoing, focusing on standards and the approaches to identify the main barriers to implementation and ensure more mainstream use of devices and sensors in trials. There is still some concern regarding the response of the regulatory authorities, however the FDA have been proactive in response to mHealth devices and have set up a specific website dealing with connected medical devices, mobile apps, and software and have issued a number of guidance documents dealing with digital health.

As we move beyond the initial hype into the maximising value of the data we face new challenges. With the increasing availability of connected devices, we have the ability to create composite endpoints by combining data from multiple devices with subjective insights from ePRO. As we transition from a snapshot in clinic data capture to real-time continuous data capture, data storage and management needs increase exponentially. The data storage requirements for a traditional 200 patient study is estimated to be in the megabytes range compared to terabytes for a study that captures sub-second accelerometer data. Beyond the storage requirements, data needs to be readily accessed and analysed, ensuring data privacy and security compliance are in line with local legal requirements such as EU General Data Protection Regulation (GDPR). This presents new challenges and opportunities for those involved in global studies using mHealth technologies. Digital platforms such as Validic, Intel, and The Hyve facilitate the scaling of data capture and aggregation from multiple sensors. Similarly, cloud based platforms such as the Amazon Web Services (AWS) and Microsoft Azure are refining their services so that in addition to the storage and database options they are now offering machine learning and analytics tools.

It is clear that wearables and sensors are seen as key components in facilitating new trial design. This approach is gaining momentum in clinical trials design. However, the true value of wearables and sensors will emerge in the coming decade as their use is moving beyond mere hype to creating patient-centric trials and the earlier availability of new therapies improving the lives of patients.
tag

Microsoft

AWS

Read Also

Change Agents in a Digital Healthcare World: People, Culture and Strategy

Change Agents in a Digital Healthcare World: People, Culture and Strategy

Charles Koontz, President & CEO, GE Healthcare IT & Chief Digital Officer, GE Healthcare
Consumer APIs and the Impact On Healthcare Technology

Consumer APIs and the Impact On Healthcare Technology

Dr. David McCallie Jr., SVP, Medical Informatics at Cerner Corporation [NASDAQ:CERN]
Achieving Information Security in Healthcare

Achieving Information Security in Healthcare

Dan Costantino, CISO, Penn Medicine
Implementation of HIT in Healthcare Practices

Implementation of HIT in Healthcare Practices

Susan DeVore, President and CEO, Premier

Weekly Brief

loading
cxoinsights
Top 10 Healthcare Tech Companies - 2018
ON THE DECK

Healthcare 2018

Top Vendors

Top Trending News

  • How Digitalisation Modernises European Insurance Industry
    How Digitalisation Modernises...
  • How Europe Leverages Drone Technology to Boost Efficiency
    How Europe Leverages Drone Technology...
  • How can European Providers Outdo Global Cloud Computing Suppliers?
    How can European Providers Outdo...
  • How Europe Plans to Minimize 5G-Induced Risks
    How Europe Plans to Minimize...
View More ›

Copyright © 2019 CIOApplicationsEurope. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy Policy |  Sitemap |  Subscribe |  About Us

follow on linkedin follow on twitter follow on rss
This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://healthcare.cioapplicationseurope.com/cxoinsights/are-wearables-and-sensors-the-key-to-disruptive-innovation-in-clinical-trialsor-merely-an-overhyped-distraction-nid-219.html